Real-world evaluation of a two-step testing algorithm for <i>Clostridioides difficile</i> infection
Michelle T. Hecker, Andrea Son, Patricia Zuccaro, Jennifer Conti, Curtis J. Donskey
Abstract
Abstract During the 4 years after implementation of the 2-step Clostridioides difficile infection (CDI) testing algorithm, 70% to 78% of patients with suspected CDI and a positive nucleic acid amplification test but a negative toxin test (NAAT+/TOX−) received CDI treatment. Overall, 73% of NAAT+/TOX− patients were classified as having probable or possible CDI.
Topics & Concepts
ClostridioidesNucleic Acid Amplification TestsMedicineC difficileAlgorithmDiagnostic testClostridium difficileInternal medicineMicrobiologyBiologyVirologyAntibioticsComputer sciencePediatricsChlamydia trachomatisClostridium difficile and Clostridium perfringens researchMicroscopic ColitisViral gastroenteritis research and epidemiology